Aitana Lebrand

Aitana Lebrand


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Current Biology
Verified
Journal Article
Closed access
PGPaul Guichard
Paul Guichard
VHVirginie Hachet
Virginie Hachet
NMNorbert Majubu
Norbert Majubu
ANAitana Neves
Aitana Neves
DDDavide Demurtas
Davide Demurtas
PGPierre Gönczy
Pierre Gönczy

4 May 2016 in Global Ecology and Biogeography
Verified
Journal Article
Closed access
PDF file
CHCurtis R. Horne
Curtis R. Horne
AHAndrew G. Hirst
Andrew G. Hirst
DADavid Atkinson
David Atkinson
ANAitana Neves
Aitana Neves
TKThomas Kiørboe
Thomas Kiørboe

1 May 2021 in Journal of Clinical Virology
Verified
Journal Article
Open access
JVJutte J. C. De Vries
Jutte J. C. De Vries
JBJulianne R. Brown
Julianne R. Brown
NCNatacha Couto
Natacha Couto
MBMartin Beer
Martin Beer
PMPhilippe Le Mercier
Philippe Le Mercier
FLF. Xavier Lopez-Labrador
F. Xavier Lopez-Labrador
Metagenomic next-generation sequencing (mNGS) is an untargeted technique for determination of microbial DNA/RNA sequences in a variety of sample types from patients with infectious syndromes. mNGS is still in its early stages of broader translation into clinical applications. To further support the development, implementation, optimization and standardization of mNGS procedures for virus diagnostics, the European Society for Clinical Virology (ESCV) Network on Next-Generation Sequencing (ENNGS) has been established. The aim of ENNGS is to bring together professionals involved in mNGS for viral diagnostics to share methodologies and experiences, and to develop application guidelines. Following the ENNGS publication Recommendations for the introduction of mNGS in clinical virology, part I: wet lab procedure in this journal, the current manuscript aims to provide practical recommendations for the bioinformatic analysis of mNGS data and reporting of results to clinicians.

1 August 2021 in Journal of Clinical Virology
Verified
Journal Article
Open access
JVJutte J. C. De Vries
Jutte J. C. De Vries
JBJulianne R. Brown
Julianne R. Brown
NFNicole Fischer
Nicole Fischer
ISIgor Sidorov
Igor Sidorov
SMSofia Morfopoulou
Sofia Morfopoulou
ECEric C.J. Claas
Eric C.J. Claas
Metagenomic sequencing is increasingly being used in clinical settings for difficult to diagnose cases. The performance of viral metagenomic protocols relies to a large extent on the bioinformatic analysis. In this study, the European Society for Clinical Virology (ESCV) Network on NGS (ENNGS) initiated a benchmark of metagenomic pipelines currently used in clinical virological laboratories. Metagenomic datasets from 13 clinical samples from patients with encephalitis or viral respiratory infections characterized by PCR were selected. The datasets were analyzed with 13 different pipelines currently used in virological diagnostic laboratories of participating ENNGS members. The pipelines and classification tools were: Centrifuge, DAMIAN, DIAMOND, DNASTAR, FEVIR, Genome Detective, Jovian, MetaMIC, MetaMix, One Codex, RIEMS, VirMet, and Taxonomer. Performance, characteristics, clinical use, and user-friendliness of these pipelines were analyzed. Overall, viral pathogens with high loads were detected by all the evaluated metagenomic pipelines. In contrast, lower abundance pathogens and mixed infections were only detected by 3/13 pipelines, namely DNASTAR, FEVIR, and MetaMix. Overall sensitivity ranged from 80% (10/13) to 100% (13/13 datasets). Overall positive predictive value ranged from 71-100%. The majority of the pipelines classified sequences based on nucleotide similarity (8/13), only a minority used amino acid similarity, and 6 of the 13 pipelines assembled sequences de novo. No clear differences in performance were detected that correlated with these classification approaches. Read counts of target viruses varied between the pipelines over a range of 2-3 log, indicating differences in limit of detection. A wide variety of viral metagenomic pipelines is currently used in the participating clinical diagnostic laboratories. Detection of low abundant viral pathogens and mixed infections remains a challenge, implicating the need for standardization and validation of metagenomic analysis for clinical diagnostic use. Future studies should address the selective effects due to the choice of different reference viral databases.

20 November 2018 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
DLDiogo Manuel Carvalho Leite
Diogo Manuel Carvalho Leite
XBXavier Brochet
Xavier Brochet
Grégory ReschGrégory Resch
Grégory Resch
YQYok-Ai Que
Yok-Ai Que
ANAitana Neves
Aitana Neves
CPCarlos A. Peña-Reyes
Carlos A. Peña-Reyes
Antibiotic resistance and its rapid dissemination around the world threaten the efficacy of currently-used medical treatments and call for novel, innovative approaches to manage multi-drug resistant infections. Phage therapy, i.e., the use of viruses (phages) to specifically infect and kill bacteria during their life cycle, is one of the most promising alternatives to antibiotics. It is based on the correct matching between a target pathogenic bacteria and the therapeutic phage. Nevertheless, correctly matching them is a major challenge. Currently, there is no systematic method to efficiently predict whether phage-bacterium interactions exist and these pairs must be empirically tested in laboratory. Herein, we present our approach for developing a computational model able to predict whether a given phage-bacterium pair can interact based on their genome. Based on public data from GenBank and phagesDB.org, we collected more than a thousand positive phage-bacterium interactions with their complete genomes. In addition, we generated putative negative (i.e., non-interacting) pairs. We extracted, from the collected genomes, a set of informative features based on the distribution of predictive protein-protein interactions and on their primary structure (e.g. amino-acid frequency, molecular weight and chemical composition of each protein). With these features, we generated multiple candidate datasets to train our algorithms. On this base, we built predictive models exhibiting predictive performance of around 90% in terms of F1-score, sensitivity, specificity, and accuracy, obtained on the test set with 10-fold cross-validation. These promising results reinforce the hypothesis that machine learning techniques may produce highly-predictive models accelerating the search of interacting phage-bacteria pairs.

28 August 2019 in Genes
Verified
Journal Article
Open access
PDF file
TJThomas Junier
Thomas Junier
MHMichael Huber
Michael Huber
SSStefan Schmutz
Stefan Schmutz
VKVerena Kufner
Verena Kufner
OZOsvaldo Zagordi
Osvaldo Zagordi
ALAitana Lebrand
Aitana Lebrand
Shotgun metagenomics using next generation sequencing (NGS) is a promising technique to analyze both DNA and RNA microbial material from patient samples. Mostly used in a research setting, it is now increasingly being used in the clinical realm as well, notably to support diagnosis of viral infections, thereby calling for quality control and the implementation of ring trials (RT) to benchmark pipelines and ensure comparable results. The Swiss NGS clinical virology community therefore decided to conduct a RT in 2018, in order to benchmark current metagenomic workflows used at Swiss clinical virology laboratories, and thereby contribute to the definition of common best practices. The RT consisted of two parts (increments), in order to disentangle the variability arising from the experimental compared to the bioinformatics parts of the laboratory pipeline. In addition, the RT was also designed to assess the impact of databases compared to bioinformatics algorithms on the final results, by asking participants to perform the bioinformatics analysis with a common database, in addition to using their own in-house database. Five laboratories participated in the RT (seven pipelines were tested). We observed that the algorithms had a stronger impact on the overall performance than the choice of the reference database. Our results also suggest that differences in sample preparation can lead to significant differences in the performance, and that laboratories should aim for at least 5–10 Mio reads per sample and use depth of coverage in addition to other interpretation metrics such as the percent of coverage. Performance was generally lower when increasing the number of viruses per sample. The lessons learned from this pilot study will be useful for the development of larger-scale RTs to serve as regular quality control tests for laboratories performing NGS analyses of viruses in a clinical setting.